Ontario expanding safe use of biosimilars

20 December 2022 - Transitioning to biosimilars will allow province to invest in and improve access to medicines. ...

Read more →

A National Medicines Policy fit for the future

20 December 2022 - An updated and strengthened National Medicines Policy has been delivered to the Australian Government. ...

Read more →

Just released National Medicines Policy sets high ambitions for better health outcomes for all Australians

20 December 2022 - Medicines Australia congratulates the Government on the release of the much anticipated National Medicines Policy, after ...

Read more →

Refreshed National Medicines Policy

20 December 2022 - The Australian Government has released an updated and strengthened National Medicines Policy.  ...

Read more →

Saskatchewan becomes sixth Canadian province to implement a biosimilar switching policy

21 October 2022 - Saskatchewan joined five provinces and one territory in implementing a biosimilar switching policy, allowing for reference ...

Read more →

National Medicines Policy draft strides ahead but still room for improvement

26 September 2022 - Stakeholders have until tomorrow night to submit their feedback on the refreshed National Medicines Policy that ...

Read more →

New PM will ‘inherit an NHS in its most challenging state for decades’

5 September 2022 - Warning comes from NHS leaders as new Prime Minister prepares to move into Number 10. ...

Read more →

Every life is worth the same, but maybe not at PHARMAC

4 September 2022 - One of the dubious consequences of our obsession with race is the collection of data on ...

Read more →

National Medicines Policy review – registrations for targeted stakeholder consultation sessions and open public forum

22 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on the revised ...

Read more →

Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes

18 August 2022 - Medicines Australia welcomes the restart of the National Medicines Policy Review, which was put on hold ...

Read more →

Restart of the National Medicines Policy review – further consultation on a revised draft

17 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised ...

Read more →

Revealed: sick state of bulk-billing

15 August 2022 - Doctors expect the national bulk-billing rate may plunge to as little as 30% within two years ...

Read more →

CADTH Advisory Panel report recommends framework for potential pan-Canadian formulary

11 July 2022 - In July 2021, the Government of Canada approached CADTH to develop a recommended framework for creating and ...

Read more →

Health Ministers and Health Chief Executives met today in Canberra to discuss priorities for the Australian health system

1 July 2022 - Health Ministers and Health Chief Executives met today in Canberra to discuss priorities for the Australian health ...

Read more →

PHARMAC joins ACT’s call for a medicines strategy

8 June 2022 - “It appears that everyone wants a dedicated Medicines Strategy apart from Andrew Little, who is too ...

Read more →